A Case of Tjalma Syndrome Coincidentally Accompanied by an Ovarian Teratoma Successfully Treated with Intravenous Immunoglobulin-G Adjunctive Therapy

´ëÇÑ·ù¸¶Æ¼½ºÇÐȸÁö 2014³â 21±Ç 2È£ p.77 ~ p.81

¹ÚÀº°æ(Park Eun-Kyoung) - Pusan National University School of Medicine Department of Internal Medicine
À̽±Ù(Lee Seung-Geun) - Pusan National University School of Medicine Department of Internal Medicine
À̼±Èñ(Lee Sun-Hee) - Pusan National University College of Medicine Department of Internal Medicine
À̽ÂÁØ(Lee Seong-Jun) - Pusan National University School of Medicine Department of Internal Medicine
³²À±Á¤(Nam Yoon-Jeong) - Pusan National University School of Medicine Department of Internal Medicine
¹ÚÁöÇý(Park Ji-Hye) - Pusan National University School of Medicine Department of Internal Medicine
±è±ÙÅÂ(Kim Geun-Tae) - Kosin University College of Medicine Department of Internal Medicine
¹Ú¿µÀº(Park Young-Eun) - Malgeunsem Hospital
ÀÌÁ¤¿í(Lee Joung-Wook) - Busan St. Mary¡¯s Medical Center
ÀÌÁØÈñ(Lee Jun-Hee) - Ilsin Christian Hospital Department of Internal Medicine
¹é½ÂÈÆ(Baek Seung-Hoon) - Ilsin Christian Hospital Department of Internal Medicine

Abstract

Tjalma or pseudo-pseudo Meigs¡¯ syndrome is a clinical con-dition that is characterized with ascites, pleural effusion, and increased serum CA-125 levels in patients with systemic lu-pus erythematosus (SLE) without the presence of ovarian tumor. On the other hand, Meigs¡¯ and pseudo-Meigs¡¯ syn-dromes represent the same manifestations with ovarian tumor. In this case report, we present a 43-year-old SLE pa-tient suffering from Tjalma syndrome with the coexistence of incidental ovarian teratoma, who was successfully treated with intravenous immunoglobulin-G adjunctive therapy af-ter inadequate response to surgical excision of the ovarian tumor, steroid, and cyclophosphamide pulse therapy.

Ű¿öµå

Systemic lupus erythematosus, Intravenous im-munoglobulin, Ascites, Pleural effusion
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Ű¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆÇ³âµµ(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå